Procedural adverse events in pediatric patients with sickle cell disease undergoing chronic automated red cell exchange
- 24 January 2022
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 62 (3) , 584-593
Abstract
Background Chronic automated red cell exchange (RCE) is increasingly employed for sickle cell disease (SCD). There is a paucity of data on the incidence of RCE adverse events (AEs) and potential patient and procedural risk factors for AEs. Methods A retrospective review of pediatric SCD patients receiving chronic RCE over 3 years was performed to determine the frequency of AEs and identify procedural and patient AE risk factors. AE incidence, AE rate, incidence rate ratios (IRRs), and relative risks (RRs) were calculated based on various procedural and patient characteristics by univariable (UV) and multivariable (MV) analyses. Results In 38 patients receiving 760 procedures, there were 150 (19.7%) AEs, 36 (4.7%) were symptomatic AEs. AE rates were 20.2 [95% CI 17.2, 23.6] and 4.8 [95% CI 3.49, 6.70] per 100 person months for AEs and symptomatic AEs, respectively. AE incidences were: hypocalcemia (117; 15.4%), dizziness (22; 3.0%), hypotension (15; 2.0%), and nausea (14; 1.8%). Patients with baseline Hct ≥30% experienced more total AEs and symptomatic AEs. Patients with pre-procedure systolic BP + thalassemia) exhibited more total AEs. IHD depletion was not associated with an increased incidence of AEs or symptomatic AEs. Conclusion SCD patients with Hct ≥30%, systolic BP <50th percentile, severe CNS vasculopathy, and possibly non-SCA genotype may be at higher risk for RCE-related AEs. The effect of IHD on AE risk is likely minimal. Individualized AE risk assessment should be performed in all SCD patients undergoing chronic automated RCE.Keywords
This publication has 19 references indexed in Scilit:
- Management of Patients with Sickle Cell Disease Using Transfusion TherapyHematology/Oncology Clinics of North America, 2016
- Effectiveness of red blood cell exchange, partial manual exchange, and simple transfusion concurrently with iron chelation therapy in reducing iron overload in chronically transfused sickle cell anemia patientsTransfusion, 2016
- Comparative evaluation of the depletion‐red cell exchange program with the Spectra Optia and the isovolemic hemodilution‐red cell exchange method with the COBE Spectra in sickle cell disease patientsJournal of Clinical Apheresis, 2015
- Advantages of isovolemic hemodilution‐red cell exchange therapy to prevent recurrent stroke in sickle cell anemia patientsJournal of Clinical Apheresis, 2011
- Analysis of the evidence for the lower limit of systolic and mean arterial pressure in childrenPediatric Critical Care Medicine, 2007
- Discontinuing Prophylactic Transfusions Used to Prevent Stroke in Sickle Cell DiseaseNew England Journal of Medicine, 2005
- Prevention of a First Stroke by Transfusions in Children with Sickle Cell Anemia and Abnormal Results on Transcranial Doppler UltrasonographyNew England Journal of Medicine, 1998
- Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusionsThe Journal of Pediatrics, 1995
- Longitudinal data analysis using generalized linear modelsBiometrika, 1986
- Blood Pressure in a National Sample of U. S. Adults: Percentile Distribution by Age, Sex and RaceInternational Journal of Epidemiology, 1973